Interferon-α improves glucose tolerance in diabetic and non-diabetic patients with HCV-induced liver disease

Experimental and Clinical Endocrinology and Diabetes

Volumn 107, Issue 6, 1999, Pages 343-349

  Konrad, T ^a   Vicini, P ^b   Zeuzem, S ^a   Toffolo, G ^c   Briem, D ^a   Lormann, J ^a   Herrmann, G ^a   Wittmann, D ^a   Lenz, T ^a   Kusterer, K ^a   Teuber, G ^b   Cobelli, C ^a   Usadel, K H ^a  

^a GOETHE UNIVERSITY   (Germany)

^b UNIVERSITY OF WASHINGTON   (United States)

^c Johann Wolfgang Goethe University ^*

Author keywords

Glucose tolerance; Hepatitis C; Insulin resistance; Insulin secretion; Interferon

Indexed keywords

ALPHA INTERFERON; C PEPTIDE; FATTY ACID; GLUCOSE; INSULIN;

ADULT; ARTICLE; CLINICAL ARTICLE; DIABETES MELLITUS; DRUG EFFICACY; GLUCOSE TOLERANCE; HEPATITIS C; HUMAN; INSULIN RELEASE; INSULIN SENSITIVITY; INTRAVENOUS GLUCOSE TOLERANCE TEST; LIVER DISEASE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

EID: 0032833142     PISSN: 09477349     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0029-1212124     Document Type: Article

References (43)

1. Allison MED, Wreghitt T, Palmer CR, Alexander GJM: Evidence for a link between hepatitis C virus infection and diabetes mellitus in a cirrhotic population. J Hepatol 21: 1135-1139, 1994
2. Bergman RN: Toward physiological understanding of glucose tolerance. Diabetes 38: 1512-1527, 1989
3. Bergman RN, Ider ZY, Bowden CR, Cobelli C: Quantitative estimation of insulin sensitivity. Am J Physiol 236: E667-E677, 1979
4. Bergman RN, Phillips LS, Cobelli C: Physiologic evaluation of factors controlling glucose tolerance in man. J Clin Invest 68: 1456-1467, 1981
5. Bogardus C, Lillioja S, Howard VB, Reaven GM, Mott D: Relationship between insulin secretion, insulin action, and fasting glucose concentration in nondiabetic and noninsulin-dependent diabetic subjects. J Clin Invest 74: 1238-1246, 1984
6. Cavallo-Perin P, Cassader M, Bozzo C, Nuccio P, Dall'Omo AM, Marucci M, Pagano G: Mechanism of insulin resistance in human liver cirrhosis. J Clin Invest 75: 1659-1665, 1985.
7. Cerasi E, Luft R: The plasma insulin response to glucose infusion in healthy subjects and in diabetes mellitus. Acta Endocrinol 55: 278-304, 1967
8. Cobelli C, Pacini G, Toffolo G, Saccœ L: Estimation of insulin sensitivity and glucose clearance from minimal model: new insights from labeled IVGTT. Am J Physiol 250: E591-E598, 1986
9. Corssmit EPM, Heijligenberg R, Endert E, Ackermas MT, Sauerwein HP, Romijn JA: Endocrine and metabolic effects of interferon-α in humans. J Clin Endocrinol Metab 81: 3265-3269, 1996
10. Del Rey A, Besedovsky H: Antidiabetic effects of interleukin 1. Proc Natl Acad Sci, 86: 5943-5947, 1989
11. Del Rey A, Monge-Arditi G, Klusman I, Besedovsky HO: Metabolic and endocrine effect of interleukin-1 in obese, diabetic Zucker fa/fa rats. Exp Clin Endocrinol Diabetes 104: 317-326, 1996
12. Fabris P, Floreani A, De Lazzari F, Betterle C, Naccarato R, Chiaramonte M: Development of type 1 diabetes mellitus during interferon alpha therapy for chronic HCV hepatitis. Lancet 340: 548, 1992
13. Garcia-Buey L, Garcia-Monzon C, Rodriguez S, Borque MJ, Garcia-Sanchez A, Iglesias R, DeCastro M, Mateos FG, Vicario JL, Balas A, Moreno-Otero R: Latent autoimmune hepatitis triggered during interferon therapy in patients with chronic hepatitis C. Gastroenterology 108: 1770-1777, 1995
14. Gray H, Wreghitt T, Alexander GJM, Turner RC, O'Rahilly S: High prevalence of hepatitis C infection in afro-caribbean patients with type 2 diabetes and abnormal liver function tests. Diabetic Med 12: 244-249, 1995
15. Guerci A-P, Guerci B, Levy-Marchal C, Ongagna J, Ziegler O, Candiloros H, Guerci O, Drouin P: Onset of insulin-dependent diabetes mellitus after hairy cell leukaemia. Lancet 343, 1167-1168, 1994
16. Henriksen JE, Alford F, Handberg A, Vaag A, Ward MG, Kalfas A, Beck-Nielsen H: Increased glucose effectiveness in normoglycemic but insulin-resistant relatives of patients with non-insulin-dependent diabetes mellitus. J Clin Invest 94: 1196-1204, 1994
17. Jacob S, Perrillo RP, Zimmermann R, Mason AL: Improved glucose metabolism after α-interferon therapy in patients with chronic hepatitis C (Abstract). Hepatology, 26: 304, 1997
18. Kahn SE, Prigeon RL, McCulloch DK, Boyko EJ, Bergman RN, Schwartz MW, Neifing JL, Ward KW, Beard JC, Palmer JP, Porte D jr: Quantification of the relationship between insulin sensitivity and β-cell function in human subjects. Diabetes, 42: 1663-1672, 1993
19. Kahn SE, Prigeon RL, McCulloch DK, Boyko EJ, Bergman RN, Schwartz MW, Neifing JL, Ward KW, Beard JC, Palmer JP, Porte D jr: The contribution of insulin-dependent and insulin-independent glucose uptake to intravenous glucose tolerance in healthy human subjects. Diabetes 43: 587-592, 1994
20. Koivisto VA, Pelkonen R, Cantell K: Effect of interferon on glucose tolerance and insulin sensitivity. Diabetes 38: 641-647, 1989
21. Kolacynski JW, Taskinen M-R, Hilden H, Kiviluoto T, Cantell K, Koivisto VA: Effects of interferon alpha on insulin binding and glucose transport in human adipocytes. Eur J Clin Invest 22: 292-299, 1992
22. Kruszynska YT, Harry DS, Bergman RN, McIntyre N: Insulin sensitivity, insulin secretion and glucose effectiveness in diabetic and non-diabetic cirrhotic patients. Diabetologia, 36: 121-128, 1993
23. Kruszynska YT, Williams N, Perry M, Home P: The relationship between insulin sensitivity and skeletal muscle enzyme activities in hepatic cirrhosis. Hepatology 8: 1615-1619, 1988
24. Kruszynska YT, Home PD, McIntyre N: Relationship between insulin sensitivity, insulin secretion and glucose tolerance in cirrhosis. Hepatology 14: 103-111, 1991
25. Letiexhe MR, Scheen AJ, Gerard PL, Bastens BH, Pirotte J, Belaiche J, LefŁbvre PJ: Insulin secretion, clearance, and action on glucose metabolism in cirrhotic patients. J Clin Endocrinol Metab 77: 1263-1268, 1993
26. Lopes EPA, Oliveira PM, Ferraz ML, Costa CHRM, Miranda W, Dib SA: Exacerbation of type 2 diabetes mellitus during interferon-alfa therapy for chronic hepatitis B. Lancet 343: 244, 1994
27. Luzi L and DeFronzo RA: Effect of loss of first-phase insulin secretion on hepatic glucose production and tissue glucose disposal in humans. Am J Physiol 257: E241-E246, 1989
28. Müller MJ, Willmann O, Rieger A, Fenk A, Selberg O, Lautz HU, Bürger M, Balks HJ, von zur Mühlen A, Schmidt FW: Mechanism of insulin resistance associated with liver cirrhosis. Gastroenterology 102: 2033-2041, 1992
29. Marchesini G, Pacini G, Bianchi G, Patrono D, Cobelli C: Glucose disposal, β-cell secretion, and hepatic insulin extraction in cirrhosis: a minimal model assessment. Gastroenterology 99: 1715-1722, 1990
30. Mason AL, Lau IYN, Hoang N, Qian KP, Alexander GJM, Xu L, Guo L, Jacob S, Regenstein FG, Zimmermann R, Everhart JE, Wasserfall C, Maclaren NK, Perrillo RP: Association of diabetes mellitus with chronic hepatitis C virus infection (Abstract). Hepatology 29: 328, 1999
31. National diabetes data group: Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 28: 1039-1057, 1979
32. Nolte W, Hartmann H, Ramadori G: Glucose metabolism and liver cirrhosis. Exp Clin Endocrinol Diabetes 103: 63-74, 1995
33. Özylikan E, Arslan M: Increased prevalence of diabetes mellitus in patients with chronic hepatitis C virus infection. Am J Gastroenterol 91: 1480-1481, 1997
34. Selberg O, Burchert W, von der Hoff G, Meyer GJ, Hundeshagen H, Radoch E, Balks H-J, Müller MJ: Insulin resistance in liver cirrhosis, positron-emission tomography scan analysis of skeletal muscle glucose metabolism. J Clin Invest 91: 1897-1902, 1993.
35. Petrides AS: Liver disease and diabetes mellitus. Diabetes Reviews 2: 2-18, 1994
36. Petrides AS, Vogt C, Schulze-Berge D, Matthews D, Strohmeyer G: Pathogenesis of glucose intolerance and diabetes mellitus in cirrhosis. Hepatology 19: 616-627, 1994
37. Piatti PM, Monti LD, Davis SN, Conti M, Brown MD, Pozza G, Alberti KGMM: Effects of an acute decrease in non-esterified fatty acid levels on muscle glucose utiliziation and forearm indirect calorimetry in lean NIDDM. Diabetologia 39: 103-112, 1996
38. Sako Y, Grill VE: A 48-hour lipid infusion in the rat time-dependently inhibits glucose-induced insulin secretion and β-cell oxidation through a process likely coupled to fatty acid oxidation. Endocrinology 127: 1580-1589, 1990
39. Schultz M, Müller R, Von zur Mühlen A, Brabant G: Induction of hypothyroidism by interferon alpha-2b. Lancet 1: 1452, 1989
40. Simó R, Hernández C, Genescà J, Jardy R, Mesa J: High prevalence of hepatitis C virus infection in diabetic patients. Diabetes Care, 19: 998-1000, 1996.
41. Toffolo G, De Grandi F, Cobelli C: Estimation of β-cell sensitivity from intravenous glucose tolerance test c-peptide data. Diabetes, 44, 845-854, 1995
42. Tong MJ, Rajender RK, Lee WM, Pockros PJ, Hoefs JC, Keeffe EB, Hollinger BE., Heathcote EJ, White H, Foust RT, Jensen DM, Krawitt EL, Fromm H, Black M, Blatt LM, Klein M. Lubina J, Consensus Interferon Study Group: Treatment of chronic hepatitis C with consensus interferon: a multicenter, randomized, controlled trial. Hepatology 26: 747-754, 1997
43. Zeuzem S, Schmidt JM, Jung-Hun L, Rüster B, Roth K: Effect of interferon alfa on the dynamics of hepatitis C virus turnover in vivo. Hepatology 23: 366-371, 1996